To compare the efficacy of carbetocin versus oxytocin in preventing postpartum hemorrhage in women undergoing vaginal delivery- A randomised controlled trial
Phase 3
- Conditions
- Health Condition 1: O720- Third-stage hemorrhage
- Registration Number
- CTRI/2024/04/066132
- Lead Sponsor
- Esther Issac
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Singleton pregnancies
Parity =3
Undergoing vaginal delivery
Exclusion Criteria
Patients with one or more of following were excluded:
underlying medical disease, including severe pre-eclampsia, eclampsia,bleeding disorders, thrombocytopenia, cardiovascular diseases, liver and renal diseases.
(2) history of oxytocin or carbetocin allergy
(3) obstetric complications, such as placental abruption and abnormal placentation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the post-partum blood loss in both the groupsTimepoint: 48 hours
- Secondary Outcome Measures
Name Time Method To compare the pre-partum and post-partum drop in haemoglobin in both the groups <br/ ><br>To compare the hemodynamic effects of both drugsTimepoint: 4hours